NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054250

Registered date:01/05/2024

A study on antiemetic drugs in breast cancer chemotherapy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedBreast Cancer
Date of first enrollment2024/05/01
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeNo nausea during the overall assessment period (0 to 120 hours) on the first course
Secondary Outcome1. Complete response 2. Complete control 3. Total control 4. Time to treatment failure 5. Daytime somnolence 6. Change in dosage of olanzapine 7. Satisfaction with antiemetic therapy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderFemale
Include criteria
Exclude criteria1. Concurrent use of antiemetic agent. 2. Start of opioid analgesic for 14 days before registration. 3. Subjects on anticonvulsant therapy. 4. Gastrointestinal obstruction (e.g. gastropyloric stenosis, intestinal obstruction). 5. Diagnosis of diabetes mellitus(e.g., on insulin or an oral hypoglycemic agent).

Related Information

Contact

public contact
Name Ayako Higuchi
Address 3-1-1 Notame Minami-ku Fukuoka city Fukuoka Japan 811-1395
Telephone 092-541-3231
E-mail higuchi.ayako.jn@mail.hosp.go.jp
Affiliation National Hospital Organization Kyushu Cancer Center Department of Pharmacy
scientific contact
Name Hiroaki Shimizu
Address 3-1-1 Notame Minami-ku Fukuoka city Fukuoka Japan
Telephone 092-541-3231
E-mail shimizu.hiroaki.bc@mail.hosp.go.jp
Affiliation National Hospital Organization Kyushu Cancer Center Department of Pharmacy